tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
OncoCyte Corp's activity chart (see below) currently has 62 price targets and 66 ratings on display.
Analysts average stock forecasts to be materialized ratio is 42.05% with an average time for these price targets to be met of 107 days.
Most recent stock forecast was given by THOMAS FLATEN from LAKE STREET on 21-May-2025. First documented stock forecast 24-Mar-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Dec-2018
$8
$4.84 (153.16%)
1 years 4 months 11 days ago
(21-May-2025)
2/6 (33.33%)
$4.93 (160.59%)
123
Buy Since 17-Mar-2021
$4.25
$1.09 (34.49%)
$4.25
1 years 4 months 19 days ago
(13-May-2025)
2/16 (12.5%)
$1.48 (53.43%)
58
Hold Since 24-May-2022
$4
1 years 6 months 6 days ago
(26-Mar-2025)
1/3 (33.33%)
$0.96 (31.58%)
16
Buy Since 24-Mar-2016
$5
$1.84 (58.23%)
$5
2 years 5 months 17 days ago
(15-Apr-2024)
1/7 (14.29%)
$2.47 (97.63%)
29
Hold Since 15-Aug-2023
$3
$-0.16 (-5.06%)
$3.5
2 years 10 months 19 days ago
(13-Nov-2023)
2/2 (100%)
$0.24 (8.70%)
2
What is OCX (OncoCyte Corp) average time for price targets to be met?
Which analyst most recently updated their price target on OCX (OncoCyte Corp)?
Which analyst has the most public recommendations on OCX (OncoCyte Corp)?
Which analyst is the currently most bullish on OCX (OncoCyte Corp)?
Which analyst is the currently most reserved on OCX (OncoCyte Corp)?
